Last reviewed · How we verify
NCT05564546: SÉSAR
Study of Chronic Exposure of the Population Living on the Atlantic Coast and on the Caribbean Coast, in Martinique, During the Stranding Period and Outside the Stranding Period of Sargassum Seaweeds
NA trial testing FeNO (fractional exhaled nitric oxide) in Obstructive Ventilatory Disorders in 173 participants. Completed in 28 March 2023.
28 March 2023
Quick facts
| Lead sponsor | University Hospital Center of Martinique |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 173 |
| Start date | 18 August 2022 |
| Primary completion | 28 March 2023 |
| Estimated completion | 28 March 2023 |
| Sites | 1 location across France |
Drugs / interventions tested
- FeNO (fractional exhaled nitric oxide)
- Spirometry
- Physical examination
- Interrogation
Conditions studied
- Obstructive Ventilatory Disorders — all drugs for Obstructive Ventilatory Disorders →
Sponsor
University Hospital Center of Martinique
Who can join
18 and older, any sex, with Obstructive Ventilatory Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Sargassum are pelagic brown sea algae. Two species grow on the surface of the ocean and drift freely with ocean currents in the form of slicks: the pelagic Sargassum fluitans and Sargassum natans. Since 2011, massive strandings of Sargassum seaweed in the French West Indies are to be deplored. In recent years, strandings have increased. In Martinique, sargassum stranding occurs mainly on the Atlantic coast. The duration of stranding from one year to another is variable, but the period during which the stranding is maximum is between April and October. The accumulation of strandings causes the compaction of algae and limits access to oxygen, which leads to anaerobic degradation which quickly results in the release of various gases, in particular hydrogen sulphide (H2S). Acute H2S poisoning is well characterized clinically according to exposure (cutaneous, respiratory, ophthalmological, digestive, neurological symptoms, etc.). On the other hand, there are very few data available on the clinical effects of prolonged, repeated exposure and most often at low doses. Among the toxic effects for which there are still uncertainties regarding long-term exposure to H2S are lung function, measured by spirometry, and airway inflammation, appreciable by measurement of FeNO (fractional exhaled nitric oxide). The investigators consider it relevant to focus on the clinical and biological characteristics of the population exposed to sargassum in Martinique, in the field, assuming that exposure to sargassum H2S causes pulmonary effects measurable by spirometry and by FeNO, during the stranding period and outside this period.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05564546
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University Hospital Center of Martinique trials
Trials by the same sponsor.
- NCT07206927 — Analysis of the Determinants of the Participation of Patients and Health Professionals of the University Hospital Center · not yet recruiting
- NCT06909591 — Transcultural and Psychometric Validation of the Lubben Social Network Scale in Older Adults Living in the French West I · not yet recruiting
- NCT06153589 — Effectiveness of Musicotherapy in Reducing Pain Induced by Leg Ulcer Care · NA · recruiting
- NCT06365359 — Systemic Lupus Erythematosus and Chlordecone Impregnation in Martinique · recruiting
- NCT06776627 — Effectiveness of an Adapted Physical Activity Program on Improving the Health-related Quality of Life of Women With Endo · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05564546 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital Center of Martinique
- Last refreshed: 13 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05564546.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing